Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net revenue		$ 172,671	$ 150,658	$ 450,312	$ 435,597
Cost of revenue	[1]	155,633	136,567	412,388	393,626
Gross profit		17,038	14,091	37,924	41,971
Operating expenses:
Product development	[1]	7,832	5,509	21,832	14,995
Sales and marketing	[1]	3,385	2,033	9,651	7,773
General and administrative	[1]	7,230	5,489	21,919	21,758
Operating (loss) income		(1,409)	1,060	(15,478)	(2,555)
Interest income		46	7	65	7
Interest expense		(187)	(277)	(626)	(817)
Other (expense) income, net		(12)	45	(44)	51
(Loss) income before income taxes		(1,562)	835	(16,083)	(3,314)
Benefit from income taxes		1,083	1,395	3,108	3,009
Net (loss) income		$ (479)	$ 2,230	$ (12,975)	$ (305)
Net (loss) income per share:
Basic		$ (0.01)	$ 0.04	$ (0.24)	$ (0.01)
Diluted	[2]	$ (0.01)	$ 0.04	$ (0.24)	$ (0.01)
Weighted-average shares used in computing net (loss) income per share:
Basic		53,950	54,645	53,668	54,339
Diluted		53,950	55,536	53,668	54,339

[1] Cost of revenue and operating expenses include stock-based compensation expense as follows:

[2] Diluted net loss per share for the three and nine months ended March 31, 2023 and for the nine months ended March 31, 2022 does not reflect any potential common stock relating to stock options, restricted stock units, or shares issuable related to the ESPP due to net losses incurred. The assumed issuance of any additional shares would be anti-dilutive.